Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia
Authors:
- S RichardsSRS Richards
- on behalf of Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG)O(on behalf of Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG)
Open Access
- 4 March 2011
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 25 (6) , 953-959
Abstract
Mercaptopurine has been used in continuing treatment of childhood acute lymphoblastic leukaemia since the mid 1950s. Recent advances in the understanding of thiopurine pharmacology indicated that thioguanine (TG) might be more effective than mercaptopurine (MP). The US and UK cooperative groups began randomised thiopurine trials and agreed prospectively to a meta-analysis. All randomised trials of TG versus MP were sought, and data on individual patients were analysed by standard methods. Combining three trials (from US, UK and Germany), the overall event-free survival (EFS) was not significantly improved with TG (odds ratio (OR)=0.89; 95% confidence interval 0.78–1.03). Apparent differences in results between trials may be partly explained by the different types of patients studied. The larger treatment effect reported in males in the US trial was confirmed in the other trials. There was heterogeneity between sex/age subgroups (P=0.001), with significant EFS benefit of TG only observed for males aged <10 years old (OR=0.70; 0.58–0.84), although this did not result in a significant difference in overall survival (OR=0.83; 0.62–1.10). Additional toxicity occurs with TG. Mercaptopurine remains the standard thiopurine of choice, but further study of TG may be warranted to determine whether it could benefit particular subgroups.Keywords
This publication has 7 references indexed in Scilit:
- Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trialBlood, 2010
- Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta‐analysisBritish Journal of Haematology, 2009
- Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trialThe Lancet, 2006
- Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92Blood, 2003
- Measuring inconsistency in meta-analysesBMJ, 2003
- Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia.Journal of Clinical Oncology, 1989
- Childhood lymphoblastic leukaemia: Sex difference in 6-mercaptopurine utilizationBritish Journal of Cancer, 1984